Avoiding Toxicity With Lung Radiation Therapy: An IASLC Perspective-Reference-Cited by-同舟云学术

Avoiding Toxicity With Lung Radiation Therapy: An IASLC Perspective

Published:2022-08 Issue:8 Volume:17 Page:961-973
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Bucknell Nicholas W.,Belderbos José,Palma David A.,Iyengar Puneeth,Samson Pamela,Chua Kevin,Gomez Daniel,McDonald Fiona,Louie Alexander V.,Faivre-Finn Corinne,Hanna Gerard G.,Siva Shankar

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference103 articles.

1. Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades;Lu;Cancer Manag Res,2019

2. Reduced lung-cancer mortality with low-dose computed tomographic screening;Aberle;N Engl J Med,2011

3. Reduced lung-cancer mortality with volume CT screening in a randomized trial;de Koning;N Engl J Med,2020

4. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial;Ball;Lancet Oncol,2019

5. Overall survival with durvalumab after chemoradiotherapy in Stage III NSCLC;Antonia;N Engl J Med,2018

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating tumor DNA kinetics: A future tool for radiation therapy personalization in lung cancer?;The Journal of Liquid Biopsy;2024-12

2. Radiomics-based hybrid model for predicting radiation pneumonitis: A systematic review and meta-analysis;Physica Medica;2024-07

3. Functional Lung Avoidance Planning Using Multicriteria Optimization;Practical Radiation Oncology;2024-05

4. Population-based survival rates after curative surgical and non-surgical treatment of stage III NSCLC since 2017;Lung Cancer;2024-04

5. Pulmonary vein dose and risk of atrial fibrillation in patients with non-small cell lung cancer following definitive radiotherapy: An NI-HEART analysis;Radiotherapy and Oncology;2024-03